Select Page

Uganda

The first Uganda Population-Based HIV Impact Assessment (UPHIA) was conducted between August 2016 and March 2017 to measure the status of Uganda’s national HIV response. UPHIA offered household-based HIV counseling and testing, with the return of results. The survey team visited over 12,000 households to collect this information.

In 2020, a second UPHIA was launched by the Ministry of Health to assess the country’s progress towards HIV epidemic control. The survey conducted over 10,000 household interviews. 

In 2021, the Uganda Refugee Population-based HIV Impact Assessment (RUPHIA 2021) was launched to estimate HIV prevalence, assess viral load suppression among HIV-positive individuals, and collect information on uptake of and access to HIV-related services among refugee populations. RUPHIA 2021 visited over 1,000 households.

Summary sheet findings can be found below.

UPHIA 2020-2021: Key Findings*

%

Annual HIV incidence among adults

%

HIV prevalence among adults

%

Viral load suppression among adults living with HIV*

95-95-95 among adults living with HIV
0%

Adults living with HIV who knew their HIV status

0%

Adults who were aware of their HIV status who were on ART

0%

Adults who were on ART who had viral load suppression

RUPHIA 2021: Key Findings**

%

HIV prevalence among adults

%

Viral load suppression among adults living with HIV*

95-95-95 among adults living with HIV
0%

Adults living with HIV who knew their HIV status*

0%

Adults who were aware of their HIV status who were on ART*

0%

Adults who were on ART who had viral load suppression*

**This estimate was based on a denominator between 25 and 49 and should be interpreted with caution.

*UPHIA 2016-2017 Summary Sheet and Final Report, as well as related reports and publications, can be found below.

Related Resources

No results found.
Recent PHIA News
ICAP to lead large population-based HIV surveys in 20 African countries
ICAP to lead large population-based HIV surveys in 20 African countries
October 21, 2014
ICAP at Columbia University has received $25 million in the first year of a $125 million, five-year award from the U.S. Centers for Disease Control and Prevention to conduct national, population-based HIV impact assessments (PHIAs) in 20 countries in sub-Saharan Africa.

This project is supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreement #U2GGH001226. The contents of this site are the responsibility of ICAP and do not necessarily reflect the views of the United States Government.  The mark “CDC” is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.

 

ICAP at Columbia University, 722 West 168th Street, New York, NY 10032
ICAP • CONTACT • PRIVACY POLICY